Home
Genes
PTK7
News

News Related to PTK7

Related coverage linked through entity extraction aliases.

IDEAYA Biosciences Reports Q4 2025 Results, Awaits Pivotal Uveal Melanoma Trial Data

Mar 11, 2026

IDEAYA Biosciences announced Q4 2025 financial results with $1.05 billion in cash reserves and confirmed 130 progression-free survival events in its Phase 2/3 OptimUM-02 trial of darovasertib for metastatic uveal melanoma, with topline results expected by late March 2026.

Genmab Advances New ADC Targeting SLITRK6 Despite Prior Discontinuations

Mar 02, 2026

Genmab is moving GEN1106, a SLITRK6-targeting ADC acquired through its $1.8bn ProfoundBio takeover, into phase 1 trials despite several recent discontinuations and the 2017 failure of the only other similar project.